Free radicals, lipoproteins and cardiovascular dysfunction

Molecular Aspects of Medicine

Volumn 13, Issue 1, 1992, Pages 5-111

  Rice Evans, Catherine ^a,b   Richard Bruckdorfer, K ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; APOLIPOPROTEIN; CAPTOPRIL; CATALASE; DEFEROXAMINE MESYLATE; ENDOTHELIUM DERIVED RELAXING FACTOR; FREE RADICAL; HEMOGLOBIN; ICOSANOID; IRON BINDING PROTEIN; LIPOPROTEIN; MEMBRANE LIPID; NITRIC OXIDE; PERFLUORO COMPOUND; PLASMA PROTEIN; POLYUNSATURATED FATTY ACID; PROSTACYCLIN; SUPEROXIDE DISMUTASE; TIOPRONIN;

ANIMAL MODEL; ATHEROSCLEROSIS; BLOOD CLOT LYSIS; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL GROWTH; CHEMICAL MODIFICATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; DNA DAMAGE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; ICOSANOID METABOLISM; IRON METABOLISM; LEUKOCYTE ADHERENCE INHIBITION; LIPID OXIDATION; LIPOPROTEIN METABOLISM; MACROPHAGE; MACROPHAGE FUNCTION; MEMBRANE DAMAGE; MONOCYTE; NONHUMAN; PHAGOCYTOSIS; PROTEIN LIPID INTERACTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REPERFUSION INJURY; REVIEW; SMOOTH MUSCLE FIBER; THROMBOCYTE; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM; ARTERIOSCLEROSIS; BLOOD; CORONARY ARTERY DISEASE; METABOLISM;

ARTERIOSCLEROSIS; CORONARY DISEASE; FREE RADICALS; HUMAN; LIPOPROTEINS; SUPPORT, NON-U.S. GOV'T;

EID: 0026470402     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/0098-2997(92)90002-H     Document Type: Review

References (362)

1. Improvement of postischaemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury
2. Uric acid provides an antioxidant defence in humans against oxidant-and radical-caused aging and cancer
3. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta
4. Endothelins
5. Multiple receptors for modified low-density lipoproteins in mouse peritoneal macrophages: differential uptake mechanisms for acetylated and oxidised low-density lipoproteins
6. Platelet activation by oxidatively modified low-density lipoproteins
7. Detection of ferryl myoglobin in the isolated ischaemic rat heart
8. Diet, lipoproteins and the progression of coronary atherosclerosis
9. Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals in the presence of iron
10. Platelet interactions with high and low-density lipoproteins
11. Chylomicrons from patients with Type V hyperlipoproteinaemia inhibit platelet function
12. Modification of low-density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells
13. Oxygen-dependent microbial killing by phagocytes
14. Protection from reperfusion injury in the isolated rat heart by post-ischaemic deferoxamine and oxypurinol administration
15. Myocardial ischaemia and reperfusion: direct evidence for free radical generation by electron spin resonance spectroscopy
16. The production of ceroid by mouse peritoneal macrophages in vitro
17. The role of lipid transfer proteins in lipoprotein metabolism
18. Vitamin E could reduce heart risk
19. Structure of human low-density lipoprotein subfractions determined by X-ray small-angle scattering
20. Ischaemic injury mediator
21. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide
22. The action of defined oxygen-centred free radicals on human low- density lipoprotein
23. Structural changes in oxidised low-density lipoproteins and of the effect of the anti-atherosclerotic drug probucol observed by synchrotron X-ray and neutron solution scattering
24. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions
25. Reperfusion-induced arrhythmias are not prevented by ibuprofen in isolated rat heart
26. Inhibition of platelet aggregation
27. The participation of coenzyme Q in free radical production and antioxidation
28. Reactivity of HO2/O−2 Radicals in Aqueous Solution
29. Iron mobilisation from ferritin by superoxide-derived from stimulated polymorphonuclear leukocytes
30. Superoxide-dependent iron release from ferritin in inflammatory diseases
31. Quantitative studies on the complexes formed between aortic mucopolysaccharides and serum lipoproteins
32. Inverse relationship between ESR spin trapping of oxyradicals and degree of functional recovery during myocardial reperfusion in isolated working rat heart
33. Low density lipoproteins cause general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism
34. Demonstration of free radical generation in “stunned” myocardium of intact dogs with the use of the spin trap alpha-phenyl-N-tert-butylnitrone
35. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion
36. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in ahterosclerotic human coronary artery and rabbit aorta
37. The mitochondrial generation of hydrogen peroxide
38. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit
39. Platelet function in familial hypercholesterolaemia in South Africa and the effects of probucol
40. Do human neutrophils make hydroxyl radical?
41. Spin trapping evidence for the lack of significant hydroxyl radical production during the respiration burst human phagocytes using a spin adduct resistant to superoxide-mediated destruction
42. Erythrocytes decrease myocardial hydrogen peroxide levels and reperfusion injury
43. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischaemia-reperfusion injury of isolated rat hearts
44. A receptor-mediated pathway for cholesterol homeostasis
45. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
46. The lipoprotein-associated coagulation inhibitor that inhibits Factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanisms of action
47. The effects of plasma lipoproteins of platelet responsiveness and on platelet and vascular prostanoid synthesis
48. The effects of low-density lipoproteins on the synthesis of cyclic nucleotides induced by prostacyclin in isolated platelets
49. Free radicals and the regulation of mammmalian cell proliferation
50. The incidence of acid-fast pigment (ceroid) in aortic atherosclerosis
51. β-carotene: an unusual type of lipid antioxidant
52. The measurement of radicals by pulse radiolysis
53. Examination of the secondary structure of proteins by deconvolved FTIR spectra
54. Interaction of tryptic peptides of apolipoprotein B-100 with dimyristoyl- phosphatidylcholine
55. Sulphydryl chemistry and solubility properties of human plasma apolipoprotein B
56. Platelet function in hypercholesterolaemia
57. Monocytes and endothelial cells oxidize low-density lipoproteins making it cytotoxic
58. Xanthine oxidase as a source of free radical damage in myocardial ischaemia
59. Glutathione peroxidase: the primary agent for the elimination of hydrogen peroxide in erythrocytes
60. 2 on platelet aggregation and adenylate cyclase activity in human type II a hypercholesterolaemia
61. Correlation of platelet aggregation, plasma factor activity and megathrombocytes in diabetic subjects with and without vascular disease
62. Arginine restores cholinergic relaxation of hypercholesterolaemic rabbit thoracic aorta
63. Enzyme mechanisms of superoxide production
64. Biosynthesis of N- and O-linked oligosaccharides of the low-density lipoprotein receptor
65. Interactions of plasma lipoproteins with human platelets
66. Minimally modified low density lipoprotein induces monocyte chemotactic protein-1 in human endothelial cells and smooth muscle cells
67. A method for the comparative assessment of antioxidants as peroxyl radical scavengers
68. Low density lipoprotein modulation of porcine coronary artery contractile response to histamine
69. Intracellular proteolytic systems may function as secondary antioxidant defences an hypothesis
70. Oxygen radicals stimulate intracellular proteolysis and lipid peroxidation by independent mechanisms in erythrocytes
71. Studies on the metal ion and lipoxygenase catalysed breakdown of hydroperoxides using electron spin resonance spectroscopy
72. Desferrioxamine and superoxide radicals
73. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages
74. Reversible thermal conformation changes in human serum low-density liporproteins
75. The modulation of ferryl myoglobin formation and its oxidative effects on low density lipoproteins by nitric oxide
76. Human apolipoprotein B: analysis of internal repeats and homology with other lipoproteins
77. Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation
78. Lycopene as the most efficient biological carotenoid singlet oxygen quencher
79. Vitamin E a lipid soluble antioxidant
80. The increased sensitivity of platelets to prostacyclin in marathon runners
81. Chemical determination of free radical-induced damage to DNA
82. Experimental study of the retinal toxicity of haemoglobin iron
83. Free Radicals and their involement during long-term myocardial ischaemia and reperfusion
84. Myoglobinaemia in the early phase of acute myocardial infarction
85. The inhibition of endothelium-dependent relaxation of rabbit aortas by low-density lipoproteins: The importance of oxidation
86. Low-density lipoproteins increase intracellular calcium in aequorin-loaded platelets
87. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent
88. Can superoxide dismutase alter myocardial infarct size?
89. Lipid peroxidation products: formation, chemical properties and biological activation
90. Oxidation of human low density lipoprotein
91. Biochemical, structural and functional properties of oxidised low-density lipoproteins
92. Vitamin E and other lipophilic antioxidants protect LDL against oxidation
93. Continuous monitoring of in vitro oxidation of human low density lipoprotein
94. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins
95. Malondialdehyde alteration of low-density lipoprotein leads to cholesterol accummulation in human monocyte-macrophages
96. Myocardial reperfusion injury
97. Glutathione redox pathway and reperfusion injury
98. Antioxidant defences and lipid peroxidation in human blood plasma
99. Ascorbate: the most effective antioxidant in human blood plasma
100. Helsinki heart study: primary prevention trial with gemfibrozil in middle- aged men with dyslipidemia
101. Superoxide an endogenous toxicant
102. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937
103. Aggregation of gel-filtered platelets by lipoproteins
104. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
105. Glutathione-dependent reduction of peroxides during ferryl and metmyoglobin interconversion: a potential protective mechanism in muscle
106. Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle
107. Low-density lipoproteins stimulate internal free calcium and prostacyclin release in endothelial cells
108. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor
109. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy
110. Analysis of the accuracy and implications of simple methods of prediciting the secondary structure of globular proteins
111. Role of intimal mucoid substances in the pathogenesis of atherosclerosis II Changes in tissue and blood mucopolysaccharides in cholesterol-fed animals
112. The role of the monocyte in atherosclerosis
113. Dietary induced atherogenesis in swine
114. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology
115. The antioxidant hypothesis of cardiovascular disease: epidermiology and mechanisms
116. Plasma concentrations of lysolecithin and other phospholipids in the healthy population and in men suffering from atherosclerotic diseases
117. Decline in coronary mortality in United States and vitamin C
118. L-Arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits
119. Binding site on macrophages that mediate uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
120. Evaluation of the secondary structure of apo B-100 in low-density lipoproteins (LDL) by infrared spectroscopy
121. Generation of reactive oxygen metabolites by phagocytosing endothelial cells
122. Inhibition of antithrombin III by lipid peroxides
123. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides
124. The LDL receptor pathway delivers arachidonic acid for eicosanoid formation in cells stimulated by platelet-derived growth factor
125. Albumin—an important extracellular antioxidant?
126. How to characterise a biological antioxidant
127. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages
128. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages
129. Effect of vitamin-C and vitamin-E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking
130. 2-activated metmyoglobin
131. Desferrioxamine as a lipid chain-breaking antioxidant in sickle cell membranes
132. Platelet low-density lipoprotein receptors
133. The influence of plasma lipoproteins on platelet aggregation in a normal male population
134. The aggregation of isolated platelets in the presence of lipoproteins and prostacyclin
135. Detection of a protein in human platelet membranes which binds low-density lipoproteins
136. Beta-migrating very low density lipoprotein attenuates endothelium-dependent relaxation in rabbit atherosclerotic aortas
137. Low level hyperlipidemia impairs endothelium-dependent relaxation of porcine coronary arteries by two mechanisms — functional change in endothelium and impairment of endothelium-dependent relaxation by two mediators
138. Myocardial ischaemia and reperfusion: a possible role for free radicals
139. Ultrastructural damage associated with reoxygenation of the anoxic myocardium
140. Free radical modification of low-density lipoprotein: mechanisms and biological consequences
141. Iron and copper promote modification of low-density lipoproteins by human arterial smooth muscle cells in culture
142. Augmented responses to vasocontrictor stimuli in hypercholesterolaemic and atherosclerotic monkeys
143. Dietary treatment of atherosclerosis abolishes hyperresponsiveness to serotonin: implications for vasospasm
144. Endothelium in control
145. Enhanced macrophage degradation of low-density lipoproteins previously incubated with cultured endothelial cells: recognition by receptors for acetylated low-density lipoproteins
146. Enhanced macrophage degradation of biologically modified low density lipoprotein
147. 2+-catalysed oxidation of human low-density lipoproteins monitored by Fourier transform infrared spectroscopy
148. Superoxide initiates oxidation of low-density lipoproteins by human monocytes
149. Immunoregulator plasma lipoproteins: role of apolipoprotein E and apolipoprotein B
150. Hydroxyl radical production and autoxidative glycosylation
151. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta
152. Inhibition of endothelium-derived nitric oxide and atherosclerosis
153. Alphatocopherol consumption during low-density-lipoprotein oxidation
154. Is the autoxidation of catecholamines involved in ischaemia-reperfusion injury?
155. Differences in the metabolism of oxidatively modified low density lipoprotein and acetylated low density lipoprotein by human endothelial cells: inhibition of cholesterol esterification by oxidatively modified low density lipoprotein
156. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification
157. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein
158. Recombinant human extracellular superoxide dismutase reduces the concentration of oxygen free radicals in the reperfused rat heart
159. Increased in-vivo and in-vitro platelet function in typeII and IV hyperlipoproteinaemia
160. Reductions in myocardial infarct size by neutrophil depletion: effects of duration of coronary occlusion
161. Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase
162. Inhibitors of NADPH oxidase as guides to its mechanism
163. Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein (a) and very-low-density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein
164. Modification of human serum low density lipoprotein by oxidation-characterisation and pathophysiological implications
165. Modified LDL impair the inhibition of platelet aggregation induced by endothelial cells
166. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging
167. Accumulation of cholesterol esters in macrophages incubated with human lipoprotein-antibody autoimmune complex
168. Rapid activation of human platelets by low concentrations of low-density lipoproteins via the phosphatidylinositol cycle
169. Complete protein sequence and identification of structural domains of human apolipoprotein B
170. Type 1 macrophage scavenger receptor contains a-helical and collagen-like coiled coils
171. Serum selenium, vitamin antioxidants and cardiovascular mortality: a 9 year follow-up study in the Netherlands
172. Lipoprotein binding proteins in the human platelet plasma membrane
173. Investigation of human plasma low density lipoproteins by three-dimensional fluorescence spectroscopy
174. Uber den Einfluss von lipoproteinen auf die ADP-induzierte thrombozytenaggregation
175. Uptake of canine β-very low-density lipoproteins by mouse peritoneal macrophages is mediated by the low-density lipoprotein receptor
176. Prevention of myocardial damage in acute myocardial ischaemia by early treatment with intravenous streptokinase
177. Carotenoids in medicine
178. 2 in inflammatory processes
179. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins
180. Interaction between fibronectin, proteoglycans and lipoproteins
181. Reaction of hematin with allylic fatty acid hydroperoxides
182. The structure of serum lipoproteins as analyzed by X-ray small angle scattering
183. The biosynthesis and metabolism of prostaglandins
184. Species, tissue and subcellular distribution of glutathione peroxidase activity
185. The oxidative modification of low density lipoproteins by macrophages
186. Blood cells and ischaemia-reperfusion injury
187. Atherosclerotic plaque caps are locally weakened when macrophages density is increased
188. Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein
189. Oxidation and release of glutathione from myocardium during reperfusion
190. Lipid Research Clinics coronary primary prevention trial results
191. Evidence that desferrioxamine cannot enter cells by passive diffusion
192. 2 and ADP
193. Vascular Responses to Endothelin-1 in Atherosclerotic Primates
194. Modulation of leukocyte-mediated myocardial reperfusion injury
195. Leukocytes and ischaemia-induced myocardial injury
196. Membrane Structure and Function
197. Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins
198. Cholesterol ester synthesis in macrophages: stimulation by β-very low density lipoproteins from cholesterol-fed animals of several species
199. Mitochondria contain a proteolytic system which can recognise and degrade oxidatively modified proteins
200. Coronary vasospasm as a possible cause of myocardial infarction
201. Oxygen-derived free radicals in post-ischaemic tissue injury
202. Vitamin E Interactions with free radicals and ascorbate
203. Human Lp(a): CDNA sequence of an apolipoprotein homologous to plasminogen
204. Effect of probucol on the physical properties of low-density lipoproteins oxidized by copper
205. Haemostatic function and cardiovascular death:early results of a prospective study
206. Cardioprotective effects of captopril in myocardial ischaemia, ischaemia/reperfusion and infarction
207. The effects of oxidation and glycosylation of human low density lipoproteins on platelet aggregation
208. Glutathione peroxidase and the destruction of hydrogen peroxide in animal tissues
209. Macrophages and atherogenesis
210. Macrophages and ceroid in atherosclerosis
211. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes
212. Prostacyclin and vessel wall biology
213. From endothelium-dependent relaxation to the L-arginine:NO pathway
214. Relationship between prostacyclin and nitric oxide in the thrombotic process
215. Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function
216. The enzymatic oxidation of desferal to a nitroxide free radical
217. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation
218. Low density lipoprotein cytotoxicity induced by free radical peroxidation
219. Role of leukocytes in acute myocardial infarction in anaethetised dogs: relationship to myocardial salvage by anti-inflammatory drugs
220. The structure of human plasma low-density lipoproteins
221. The role of calcium in the ischaemic myocardium
222. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs
223. Lipoproteins and the inhibitory effect of human endothelial cells on platelet function
224. Intracellular mechanisms for the decomposition of a lipid hydroperoxide I. Decomposition of a lipid peroxide by metal ions, haem compounds and nucleophiles
225. 2+-catalysed oxidation of human low density lipoprotein
226. Linoleic acid and coronary heart disease
227. Linoleic acid and coronary heart disease
228. Linoleic acid and coronary heart disease
229. Insolubilization of low density lipoprotein induces cholesterol accumulation in cultured subendothelial cells of human aorta
230. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein
231. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
232. Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis
233. Reduction of heme by lipid peroxides and its potential relevance to understanding the control of cyclooxygenase activity
234. The effect of LDL on the contractile response to 5-HT in rabbit aortas
235. Inhibition of endothelium-dependent relaxation by oxidised low-density lipoproteins
236. Modification of low density lipoproteins by polymorphonuclear cell elastase leads to enhanced uptake by human monocyte-derived macrophages via the low density lipoprotein receptor pathway
237. Lysophosphatidylcholine concentrations and metabolism in aortic intima and media: effect of nutritionally induced atherosclerosis
238. Metabolism of lysolecithin in vivo: effects of hyperlipaemia and atherosclerosis in squirrel monkeys
239. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron
240. Scavenging of hypochlorous acid and of myoglobin-derived oxidants by the cardioprotective agent mercaptopropionylglycine
241. Oxidatively modified low-density lipoproteins a potential role in recruitment and retention of monocyte/macrophages during atherosclerosis
242. Lysophosphatidylcholine: a chemotactic factor for human myocytes an its potential role in atherogenesis
243. Isolation of macrophage receptor for proteins modified by advanced glycosylation end products
244. Endothelium-dependent relaxation, cholesterol content and high energy metabolite balance in Watanabe hyperlipaemic rabbit aorta
245. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins
246. Leucocyte ascorbic acid and its relationship to coronary heart disease
247. Hypothesis — lipoprotein(a) is a surrogate for ascorbate
248. Early treatment with desferrioxamine limits myocardial ischemia/reperfusion injury
249. The anatomy and physiology of reverse cholesterol transport
250. Sensitivity of tryptophan and related compounds to oxidation induced by lipid peroxidation. Application to human serum low- and high-density lipoproteins
251. Iron-mediated oxidative stress in erythrocytes
252. Iron-mediated oxidative stress in erythrocytes
253. t-Butyl hydroperoxide-induced pertubations of human erythrocytes on a model for oxidant stress
254. The interaction of desferrioxamine and hydroxypyridone compounds with haemoglobin and erythrocytes
255. The suppression of iron release from activated myoglobin by physiological electron donors and desferrioxamine
256. Plasma antioxidants and coronary heart disease: Vitamins C and E and Selenium
257. Low plasma vitamins E and C. Increased risk of angina in Scottish men
258. Oxidized LDL increase free cholesterol and fail to stimulate cholesterol esterification in murine macrophages
259. Circulating immune complexes, immunoglobulins, complement, antibodies to dietary antigens, cholesterol and lipoproteins levels in patients with occlusive coronary lesions
260. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits
261. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits
262. Fluorescence study of tryptophan photolysis
263. The pathogenesis of atherosclerosis — an update
264. The pathogenesis of atherosclerosis
265. Hyperlipidaemia and atherosclerosis
266. The role of endothelial injury in atherosclerosis
267. A platelet-dependent serum factor that stimulates the proliferation of arterial muscle cells in vitro
268. Tumours and iron: the use of electron spin resonance
269. Vasoconstriction: a novel activity for low density lipoprotein
270. The production of free radicals during the oxidation of cysteine and their effect on isolated rat hepatocytes
271. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease
272. Interactions of Serum Copper, Selenium and Low Density Lipoprotein Cholesterol in Atherogenesis
273. Lipoprotein(a). Bailliere
274. Reduction in reperfusion injury by blood-free reperfusion after experimental myocardial inferction
275. Non-enzymatic glycosylation of human serum lipoproteins
276. Initiation of atherosclerotic lesions in cholesterol fed rabbits, II: selective retention of of LDL vs selective increases in LDL permeability in susceptible sites of arteries
277. Platelets and foam cells in the evolution of atherosclerosis
278. Membrane microviscosity and human platelet function
279. Pharmacological approaches to the modulation of plasma cholesterol
280. Studies on the effects of antioxidants and inhibitors of radical generation on free radical production in the reperfused rat heart using electron spin resonance spectroscopy
281. Biochemistry of oxidative stress
282. 2 and Lyso-PAF in Male Volunteers
283. Cellular aspects of transcapillary exchange
284. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery
285. Free radicals and myocardial ischaemia and reperfusion injury
286. reduction of experimental canine reperfusion injury by a monoclonal antibody that inhibits leukocyte adhesion
287. Pulse radiolysis of aqueous solutions of sodium azide: reaction of azide radical with tryptophan and tyrosine
288. Free radical mechanism in tissue injury
289. Free radical and prostaglandin disturbances in cancer
290. Correlations and apparent contradictions in the assessment of oxidant stress in vivo
291. Risk factors in atherosclerotic lesions
292. 2 mimics cell mediated oxidative modification
293. Lipid and lipoprotein effects on endothelial eicosanoid formation
294. Effect of human plasma lipoproteins on prostacyclin production by cultured cells
295. 125I-labelled low density lipoprotein
296. Lipoproteins and Atherogenesis — Current Concepts
297. Beyond cholesterol — modifications of low-density lipoprotein that increase its atherogenicity
298. Oxidation of human low density lipoprotein results in derivatisation of lysine residues of apoliprotein ß by lipid peroxidation decomposition products
299. Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low-density lipoprotein phospholipids
300. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL
301. Effect of alpha-tocopherol administration on platelet function in man
302. Vitamin E An inhibitor of platelet release reaction
303. Antioxidant activity of albumin-bound bilirubin
304. Effect of cholesterol on production of thromboxane B2 by platelets in vitro
305. In vivo lipid peroxidation: measurement via exhaled pentane and protection by vitamin E
306. Beta-very low density lipoprotein pretreatment of endothelial monolayers increases monocyte adhesion
307. Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins
308. Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins
309. Oxidized low density lipoprotein stimulates prostacyclin production by human vascular endothelial cells
310. Vitamin C and cardiovascular risk factors
311. Generation of superoxide by the NADH dehydrogenase of bovine heart mitochondria
312. Free radicals, myocytes and reperfusion injury
313. The formation of free radicals by cardiac myocytes under oxidative stress and the effects of electron donating drugs
314. 2 release by lung mitochondria and microsomes
315. Prevention of post-ischaemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone and the antioxidant cyanidanol-3
316. Purification and characterisation of a prostaglandin endoperoxide synthetase from sheep vesicular glands
317. Role of endothelial cells and their products in the modification of low-density lipoproteins
318. Visualization of the binding, endocytosis and transytosis of low density lipoproteins in the arterial endothelium in situ
319. Release and Vascular Activity of Endothelium-Derived Relaxing Factor in Atherosclerotic Rabbit Aorta
320. Factors regulating the metabolism of low-density lipoprotein-proteoglycan complex in macrophages
321. Inhibition of adriamycin-promoted microsomal lipid peroxidation by β-carotene, a-tocopherol and retinol at high and low oxygen partial pressures
322. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease
323. Specific macrophage receptor activity for advanced glycoylation end products (AGE) inversely correlates with insulin levels in vivo
324. Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients
325. Toxicity of human haemoglobin solution infused into rabbits
326. Effect of hydrogen peroxide on prostaglandin production and cellular integrity in cultured porcine aortic endothelial cells
327. Cause and course of atherosclerosis
328. Autoantibodies to glycosylated proteins in the plasma of patients with diabetes mellitus
329. Effect of lysophosphatidylcholine on atherosclerotic rabbit arteries
330. Fragmentation of proteins by free radicals and its effect on their susceptibility to enzymic hydrolysis
331. Free radicals, lipids and protein degradation
332. Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100
333. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment
334. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
335. Colocalization of 15-Lipoxygenase Messenger RNA and Protein with Epitopes of Oxidized Low Density Lipoprotein in Macrophage-Rich Areas of Atherosclerotic Lesions
336. Gene Expression in Macrophage-Rich Human Atherosclerotic Lesions — 15-Lipoxygenase and Acetyl Low Density Lipoprotein Receptor Messenger RNA Colocalize with Oxidation Specific Lipid-Protein Adducts
337. Cholesterol ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract
338. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein
339. Effect of blood on the activity and persistence of antigen-induced inflammation in the rat air pouch
340. Protection by superoxide dismutase and catalase in isolated rat heart reperfused after prolonged cardioplegia: combined study of metabolic, functional and morphometric ultrastructural variables
341. Oxidation of oxymyoglobin to metmyoglobin with hydrogen peroxide: Involvement of a ferryl intermediate
342. Enhanced in vivo platelet release reaction and malondialdehyde formation in patients with hyperlipidaemia
343. An immunochemical marker of low density lipoprotein oxidation
344. Modulation of coronary vasomotor tone in humans-progressive endothelial dysfunction with different early stages of coronary atherosclerosis
345. Studies on oxidized low density lipoproteins. Controlled oxidation and a prostaglandin effect
346. Adenine nucleotide depletion and contractile dysfunction in the “stunned” myocardium